Neurotensin(8-13): comparison of novel analogs for stimulation of cyclic GMP formation in neuroblastoma clone N1E-115 and receptor binding to human brain and intact N1E-115 cells.
Neurotensin(8-13): comparison of novel analogs for stimulation of cyclic GMP formation in neuroblastoma clone N1E-115 and receptor binding to human brain and intact N1E-115 cells.
复制标题
神经降压素 (8-13):比较刺激神经母细胞瘤克隆 N1E-115 中环 GMP 形成的新型类似物以及与人脑和完整 N1E-115 细胞结合的受体。
DOI:
10.1016/0006-2952(89)90637-0
复制
发表时间:
1989
影响因子:
5.8
通讯作者:
Richelson,E
中科院分区:
文献类型:
--
作者:
Gilbert,JA;McCormick,DJ;Pfenning,MA;Kanba,KS;Enloe,LJ;Moore,A;Richelson,E
Neurotensin(8–13), the carboxyl-terminal portion of neurotensin, is 4–50 times more potent than native neurotensin in binding to intact neuroblastoma N1E-115 cells and human brain tissue and in stimulation of intracellular cyclic GMP production and inositol phospholipid hydrolysis in clone N1E-115 (Gilbert JA and Richelson E,Eur J Pharmacol99: 245–246, 1984; Gilbert JAet al.,Biochem Pharmacol35: 391–397, 1986; Kanba KSet al.,J Neurochem46: 946–952, 1986; and Kanba KS and Richelson E,Biochem Pharmacol36: 869–874, 1987). A series of novel analogs of neurotensin (8–13) was synthesized, and a structure-activity study was done comparing the abilities of these peptides to stimulate intracellular cyclic GMP production in intact neuroblastoma clone N1E-115 and to inhibit the binding of [3H]neurotensin to these cells and to membranal preparations from human brain. A direct correlation was found for each analog between itsEC50, for biochemical activity and itsKDfor binding ability in studies with clone N1E-115. Furthermore, a strong correlation existed for each peptide between itsKDfor binding to neurotensin receptors on these cells and itsKDfor binding to neurotensin receptors in human brain tissue. In this study, the residues that were important to the biochemical and binding activities of neurotensin (8–13) proved to be identical to the amino acids that are necessary for the functional integrity of native neurotensin (Gilbert JAet al.,Biochem Pharmacol35: 391–397, 1986).